tm
Seeing Is Believing
tm
Seeing Is Believing
ATRS is currently covered by 4 analysts with an average potential upside of $1.56 (40.32%) from yesterday's end of day stock price of $. Antares Pharma activity chart has currently 14 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 26% with an average time for these price targets to be met of 152 days.
Highest price target for ATRS is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by ELLIOT WILBUR from RAYMOND JAMES on 14-Apr-2022. First documented stock forecast 23-Jun-2017.
Currently, out of the existing stock ratings of ATRS - 4 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$0.41 (7.33%)
6
1 years 7 months 26 days ago
0/3 (0%)
$0.44 (7.91%)
Buy
5.6
$0.01 (0.18%)
6
1 years 7 months 26 days ago
2/4 (50%)
$0.04 (0.72%)
374
Buy
5.6
$0.01 (0.18%)
5
1 years 7 months 26 days ago
4/5 (80%)
$1.09 (30.38%)
386
Buy
7
1 years 7 months 27 days ago
0/1 (0%)
$2.85 (68.67%)
Buy
7
$1.41 (25.22%)
7
5 years 1 months 4 days ago
0/2 (0%)
$3.39 (93.91%)
What is ATRS (Antares Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on ATRS (Antares Pharma) with a proven track record?
Which analyst has the current lower performing score on ATRS (Antares Pharma) with a proven track record?
Which analyst has the most public recommendations on ATRS (Antares Pharma)?
Which analyst is the currently most bullish on ATRS (Antares Pharma)?
Which analyst is the currently most reserved on ATRS (Antares Pharma)?
